or Try an Advanced Search...

    Molecule Therapeutics Stocks List

    Symbol Grade Name % Change
    ZNTL F Zentalis Pharmaceuticals, Inc. -1.77
    CYTK D Cytokinetics, Incorporated 1.53
    KZR F Kezar Life Sciences, Inc. 1.93
    ARDX D Ardelyx, Inc. 2.72
    ENTX B Entera Bio Ltd. 4.50
    MNOV F MediciNova, Inc. 6.98
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Biotechnology Cancer Clinical Development Hormones Amyotrophic Lateral Sclerosis Antiestrogens Asthma Autoimmunity Breast Cancer Bronchial Asthma Central Nervous System Disorders Chronic Kidney Disease Constipation Cytokine Disease Drug Design Drugs Dysfunction End Stage Renal Disease

    Related ETFs - A few ETFs which own one or more of the above listed Molecule Therapeutics stocks.

    Symbol Grade Name Weight
    BBC C Virtus LifeSci Biotech Clinical Trials ETF 3.16
    HRTS D Tema Cardiovascular and Metabolic ETF 2.93
    XBI C SPDR S&P Biotech ETF 2.45
    BTEC C Principal Healthcare Innovators Index ETF 2.09
    LABU D Direxion Daily S&P Biotech Bull 3X Shares 1.75
    View all Molecule Therapeutics ETFs...
    Compare ETFs
    Compare BBC to BTEC Compare HRTS to BTEC Compare XBI to LABU

        Molecule Therapeutics Stocks Recent News

        Date Stock Title
        May 2 ARDX Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates
        May 2 ARDX Ardelyx up 13% on quarterly results beat
        May 2 ARDX Ardelyx GAAP EPS of -$0.11 beats by $0.04, revenue of $46.02M beats by $9.63M
        May 2 ARDX Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
        May 1 ARDX Ardelyx Q1 2024 Earnings Preview
        May 1 CYTK Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
        May 1 ARDX Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
        Apr 30 ARDX Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        Apr 30 MNOV MediciNova (NASDAQ:MNOV) investors are sitting on a loss of 89% if they invested five years ago
        Apr 29 CYTK Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
        Apr 26 ENTX Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade
        Apr 26 CYTK Cytokinetics names Sung Lee as CFO
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Biotechnology Cancer Clinical Development Hormones Amyotrophic Lateral Sclerosis Antiestrogens Asthma Autoimmunity Breast Cancer Bronchial Asthma Central Nervous System Disorders Chronic Kidney Disease Constipation Cytokine Disease Drug Design Drugs Dysfunction End Stage Renal Disease
        Molecule Therapeutics

        Molecule Therapeutics is a branch of biotechnology that focuses on the development of therapeutic molecules for the treatment of diseases. This includes the development of small molecules, peptides, proteins, and nucleic acids for therapeutic use. Molecule Therapeutics also involves the study of the structure and function of molecules, as well as the development of new methods for drug delivery.

        Browse All Tags